The recent challenges in global chains have highlighted the necessity of securing essential medications like Ivermectin. Dependence on overseas vendors exposes countries to considerable vulnerabilities, including delivery delays, price fluctuations, and even political threats. Transitioning towards domestic production of Ivermectin offers a multitu